Bioinformatics an NIH priority
Article Abstract:
Bioinformatics is now a National Institutes of Health (NIH) priority. The agency does not keep pace with private industry in updating computer resources. Lack of expertise affects the more established scientists and training is to be set up. Also, NIH's Office of Protection from Research Risks may be moved to the Department of Health and Human Services. The office monitors federally funded research nationwide to ensure that human subjects are not harmed.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Sound of silence
Article Abstract:
Hearing loss, which is generally incurable, as the sensory cells of the cochlea do not regenerate, could be treated with gene therapy to bring back the lost cochlear hair cells. An experiment in deaf guinea pigs have revealed that viral introduction of the transcription factor Math1 into the damaged cochlea could bring back most of the lost hair cells and partially restore the hearing in deaf guinea pigs.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Distribution of mental health funding questioned
Article Abstract:
The National Alliance for the Mentally Ill has charged that the National Institute of Mental Health (NIMH) has not spent sufficient funds on research into bipolar disorder, schizophrenia, and severe depression. The NIMH has responded that it spends approximately 80% of its entire budget on mental illness and behavioral science research.
Publication Name: Nature Medicine
Subject: Health
ISSN: 1078-8956
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Timely toxicology. Water Pollution and Human Health in China
- Abstracts: Factors influencing the outcome of congenital heart disease detected prenatally
- Abstracts: Inhibition of telomerase limits the growth of human cancer cells. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
- Abstracts: Inhibition of telomerase limits the growth of human cancer cells. part 2 A super way to kill cancer cells
- Abstracts: Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis